Health
Study characterizes cisplatin-induced hearing loss in pediatric cancer patients – News-Medical.Net
Cisplatin is one of the most effective chemotherapy agents, used in just under half of pediatric cancer cases.
Cisplatin is one of the most effective chemotherapy agents, used in just under half of pediatric cancer cases. Permanent hearing loss is a common side effect of this medication, but until now, studies have been too small and too varied to accurately characterize this risk.
Today in The Lancet Child & Adolescent Health, investigators at Children’s Hospital Los Angeles published results of the largest study of cisplatin-induced hearing loss to date. The study establishes the first benchmarks for the…
-
Business17 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
Business11 hours agoAustralian rare earths companies trading at record levels as China tightens export controls
-
Business9 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?
-
Noosa News22 hours agoHomicide investigation, Torquay – Sunshine Coast